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Potenciais interações relacionadas ao uso de medicamentos, plantas medicinais e fitoterápicos 
em mulheres no período do climatério 
Potential drug interactions in relation with the use, medicine plants and herbal in premenopausal 
women period 
Potenciais interacciones de la droga con el uso, plantas medicinales y hierbas en las mujeres en 
periodo premenopáusicas 
 Gabriela Tassotti Gelatti 1, Karla Renata de Oliveira 2, Christiane de Fátima Colet 3 
 
 
 
Objective: To identify the potential interactions resulting from the use of medicinal plants and herbal 
concomitant with medicine used by menopausal women. Method: This was a cross-sectional, descriptive and 
analytical study of 87 climacteric women receiving care at Family Health Strategies VII and VIII of the city 
of Ijuí/RS and that are part of institutional research "Multidimensional study of women in the aging process". 
Results: Of the 87 women studied, 55 used at least one medicinal plant and nine women used at least one 
concomitant herbal medicinal products, a total of 26 women exposed to interactions between plants and 
medicines and six women exposed to interactions between herbal medicines and medicines. Conclusion: 
The study revealed high exposure to interactions resulting from the use of medicinal plants and herbal with 
medicines in the users of the Unit Health System in the city and the monitoring of the use of these products 
by health professionals is necessary. Descriptors: Climacteric, Herbal medicine, Medicinal plants, Drug 
interactions, Family health strategy. 
 
 
 
Objetivo: Identificar as potenciais interações decorrentes do uso de plantas medicinais e fitoterápicos 
concomitante a medicamentos utilizados por mulheres climatéricas. Método: Trata-se de um estudo 
transversal, descritivo e analítico realizado com 87 mulheres climatéricas atendidas nas Estratégias de Saúde 
da Família VII e VIII do município de Ijuí/RS, e que fazem parte da pesquisa institucional “Estudo 
multidimensional de mulheres no processo de envelhecimento”. Resultados: Das 87 mulheres estudadas, 55 
utilizavam pelo menos uma planta medicinal e nove mulheres utilizavam pelo menos um fitoterápico 
concomitante a medicamentos, totalizando 26 mulheres expostas a interações entre plantas e medicamentos 
e seis mulheres expostas a interações entre fitoterápicos e medicamentos. Conclusão: O estudo revelou alta 
exposição a interações decorrentes do uso de plantas medicinais e fitoterápicos concomitante a 
medicamentos em usuárias do Sistema Único de Saúde municipal, mostrando-se necessário o 
acompanhamento do uso desses produtos pelos profissionais de saúde. Descritores: Climatério, Fitoterapia, 
Plantas medicinais, Interações de medicamentos, Estratégia de saúde da família.  
 
 
 
Objetivo: Identificar las interacciones potenciales que pudieran resultar del uso de plantas medicinales y 
fármaco concomitante a base de hierbas utilizados por las mujeres menopáusicas. Método: Se realizó un 
estudio transversal, descriptivo y analítico de 87 mujeres climatéricas que reciben atención en salud de la 
familia Estrategias VII y VIII del municipio de Ijuí/RS y que son parte de la investigación institucional "Estudio 
multidimensional de las mujeres en el proceso de envejecimiento". Resultados: De las 87 mujeres 
estudiadas, 55 utilizaron al menos una planta medicinal y nueve mujeres utilizan al menos uno de los 
medicamentos a base de hierbas concomitantes, un total de 26 mujeres expuestas a las interacciones entre 
plantas y medicinas y seis mujeres expuestas a las interacciones entre los medicamentos a base de hierbas 
y medicinas. Conclusión: El estudio reveló una alta exposición a las interacciones que resultan del uso de 
plantas medicinales y fármaco concomitante de hierbas en los usuarios del sistema único de salud municipal 
y el seguimiento de la utilización de estos productos por los profesionales de la salud es necesario. 
Descriptores: Climaterio, Medicina natural, Plantas medicinales, Interacciones medicamentosas, Estrategia 
de salud para la familia. 
 
1 Pharmacist, Master’s Student of the Postgraduation Program Stricto Sensu in Integral Attention to Health - Unicruz/Unijuí.  E-
mail: gabriela.gelatti@hotmail.com 2 Pharmacist, Master of Biological Sciences: Biochemist, Federal University of Rio Grande do 
Sul. E-mail: karla@unijui.edu.br 3 Pharmacist, Master in Pharmaceutical Sciences from the Federal University of Rio Grande do 
Sul. E-mail: chriscolet@yahoo.com.br 
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onsumption of medicinal plants and herbal medicines has 
increased worldwide over the years, and this growth is related to several factors, among 
which stand out the disappointment with the results obtained in conventional treatments; 
undesirable effects and damage caused by abuse and/or misuse of medicines; difficulties 
of access to medicines and even the popular belief that natural products are harmless.1 
According to Veiga Jr. et al.2 the population of the poorest countries make use of 
medicinal plants by tradition and the absence of viable economic alternatives, while in 
developed countries there has been increased use of phyto influenced by fads that 
stimulate the consumption of natural products. 
Brazilians are also increasingly interested in treatments "safe" and "natural" to 
promote a healthier life. In Brazil, about 82% of the population use products based on 
medicinal plants,3 of which the use is higher for women, and the use of drugs. This data 
can be justified from the feminine behavior, given that women have a greater concern 
for health, are more attentive to symptoms of disease and seek more health services than 
men.4-5-6 Specifically, during menopause, many women experience vasomotor, 
neuropsychiatric symptoms and sexual dysfunction. Still, the effects of hormonal changes 
may increase the incidence of hypertension, cardiovascular disease, osteoporosis, 
hypothyroidism, obesity, diabetes mellitus and psychosocial disorders. In many cases, 
treatment for these clinical manifestations drugs are used, increasing in this age range to 
medicate.7 
For many patients, the use of a single drug is not enough, and when two or more 
medicines are prescribed, not always the desired benefit is achieved, since they can 
interact negatively, which may increase or diminish the therapeutic effect or toxic effect 
of one or the other.8-9 It should be noted that these interactions are not restricted to the 
world of synthesized chemicals, but can occur among those present in plants that are 
used as teas, syrups and herbal.10 
It is noteworthy that the risk of the occurrence of interactions involving medicinal 
plants and herbal medicines may be greater than the interactions between medicines, as 
these usually contain unique chemicals, while almost all plants (even products containing 
only a plant) containing mixtures of substances pharmacologically active, increasing the 
possibility of interactions occur.11-12 
C 
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Thus, this study aims to identify the potential interactions resulting from the use of 
medicinal plants and herbal concomitant drug used by women in the climacteric period. 
 
 
 
 
 
 
 
 
It is a study of cross-sectional descriptive and analytical type. The sample 
consisted of 87 climacteric women attending the Family Health Strategy (FHS) VII and VIII 
of the municipality of Ijuí/RS and that are part of institutional research called 
"multidimensional study of women in the aging process" approved by the Ethics Committee 
Regional Research at the University of the State of Rio Grande do Sul Northwest (UNIJUÍ) 
under the Embodied Opinion nº 864.988. 
  Data were collected by applying a questionnaire at the residence of the 
participants after the signing of the Informed Consent and, from December 2013 to 
February 2014. 
The variables of interest for data collection were: sociodemographic 
characteristics, use of medicinal plants, herbal and medicine. To identify and herbal 
medicines has asked the respondent to submit the used of each product box and failing, 
prescription in use. Among the cited plants, those that have provided interviewed were 
collected and identified as the species and/or botanical family, by an agronomist. The 
samples contained parts like leaves, flowers and fruits, giving priority to adult branches. 
Those that were not available at the time of the interview, was considered the self-
report. 
We used the concepts described in Herbal form of the Brazilian Pharmacopoeia29 
which defines: 
a) Medicinal plant - plant species, cultivated or not, used for therapeutic purposes; b) 
Phytotherapic - the product of medicinal plant or its derivatives, except single substances 
with prophylactic purpose, curative or palliative; c) Drug - pharmaceutical product, 
technically obtained or prepared, containing one or more drugs and other substances with 
prophylactic, curative, palliative or diagnostic purposes, where they are established the 
prescriber-pharmacist-user relationship. 
The drugs were classified according to first and second levels of the Anatomical 
Therapeutic Chemical Code (ATC).13 To identify and classify the interactions arising from 
the use of concomitant medicinal plants and herbal medicines have been used in the 
Micromedex®14 and Medscape,15  databases  website drugs.com,16 beyond books: DRUG 
INTERACTIONS OF STOCKLEY17 and ADVERSE DRUG INTERACTIONS.18 When the same 
interaction found in books and databases, data was prioritized basis. To identify 
interactions, were excluded herbal with more than one active component. 
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Interactions were classified according to the severity according to the website 
drugs.com16 and databases Micromedex14 and Medscape15 and the latter not 
conceptualizes the smallest interactions: 
a) Higher/series - combinations should be avoided because the risk outweighs the benefit 
of interaction;16 may have life-threatening and require medical intervention to reduce or 
avoid serious adverse effects;14 must use other alternatives.15 
b) Moderate/significant - should generally avoid combinations and use them only in 
special circumstances;16 may result in worsening of the clinical condition of the patient, 
requiring modification of the established drug therapy;14 should monitor the use.15 
c) Minor - should assess the risk and consider an alternative medication, take steps to 
circumvent the risk of interaction and/or institute a monitoring plan;16 when the patient 
change in clinical status, but does not require modification of drug therapy.14 
 Also considered were the concepts presented in the book of DRUG INTERACTIONS 
OF STOCKLEY17 that classifies interactions: interactions in which there is an outcome that 
threatens the life, in this case is considered better to avoid the simultaneous use; 
interactions where simultaneous use can result in significant risk to the patient, requiring 
dosage adjustment and rigorous monitoring; interactions where there is a potentially 
dangerous outcome, but how data is scarce, the findings on the interaction are difficult 
to draw; There is doubt about the result of concurrent use, and therefore you may need 
to educate patients about possible adverse effects and/or consider monitoring; and 
interactions that are not considered clinically important. The book ADVERSE DRUG 
INTERACTIONS18 do not classify the interactions as the severity. 
In cases of disagreement between the data bases, as regards the interaction 
classification, the most serious was adopted. 
To analyze the data we used the Statistical Package for Social Sciences (SPSS). For 
categorical variables we used absolute and relative frequency, and quantitative variables, 
mean and standard deviation. It was performed Student t test for independent samples 
to compare the means of variables: number of medicinal plants used x number of drugs 
used. It was considered significant at p<0,05. 
This study is a subproject linked to institutional research mentioned above and 
was approved by the Research Ethics Committee of UNIJUÍ Embodied under Opinion nº 
524.871. 
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The 87 study participants had a mean age of 51,5±8,4 years, with a minimum of 34 
and maximum of 69 years. Regarding marital status, 49 (56,98%) are married, among 
women with their own income, 37 (43,02%) reported receiving one to two minimum 
salaries. As for education, it was found that 38 (44,19%) women did not complete primary 
school. 
The use of medicinal plants was reported by 82 (94,3%) respondents, averaging 
4,24±2,89 plants per woman. The majority (79,27%) mentioned knowing the use of 
medicinal plants for traditional indications, transmitted from generation to generation. 
Among the plants acquire sites, 46 (56,09%) reported cultivate in their homes. In each 
use, 59 (71,95%) women were using a single type of medicinal plant and 23 (28,05%) used 
mixtures. Were cited 82 different species of medicinal plants, and the most used were 
Matricaria recutita (chamomile) (n=40), Achyrocline satureioides (Marcela) (n=38), 
Cymbopogon citratus (lemon) (n=25), Plectranthus barbatus (false Boldo) (n=24) and 
Mentha x piperita (Mint) (n=17). 
 The high use of medicinal plants was also observed in Teutonic/RS, one practice 
among 92,9% of respondents, with an average of 4,8±3,7 plants/person. Other data similar 
to the present study were observed: 74,8% of respondents mentioned knowing the use of 
medicinal plants through relatives, and also 58,6% of the plants mentioned are grown in 
the residence of respondents.19 Whereas the municipality Teutonic is located in central 
and Ijuí in the northwest of the Rio Grande do Sul (RS), one can infer that the high use of 
medicinal plants is a state characteristic. But in other regions of Brazil the reality is 
similar, whereas in Uberlandia/MG and Sao Paulo/SP was found that 76,7% and 68% of 
respondents, respectively, reported using some medicinal plant.20-21 
The World Health Organization (WHO) has encouraged the use of complementary 
therapies in health systems. In this sense, Brazil, in 2006, the Ministry of Health approved 
the National Policy on Integrative and Complementary Practices in the Unified Health 
System (SUS) (PNPIC)22 and the National Policy on Medicinal Plants and Herbal Medicines 
(PNPMF)23 including in its guidelines to promote the rational use of medicinal plants and 
herbal medicines in SUS. Most experiments on the public network is based on the Living 
Pharmacy model,24 established by the Ministry of Health through Ordinance No. 886, of 
April 20, 2010.25 Other advances are noteworthy, such as the publication of the National 
List of Medicinal Plants interest to the SUS (RENISUS);26 publication of RDC No. 10/2010,27 
in the Annex I lists 66 species of medicinal plants, as well as information for their use; 
preparation of Herbal form of the Brazilian Pharmacopoeia;28 include eight herbal cast in 
the National List of Essential Medicines (RENAME);29 Instruction No. 2/201430 which brings 
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a list of 27 authorized herbal medicines and traditional herbal 16 products with 
information for their use; besides the approval of policies and state and local programs 
and investments in structuring programs/projects phytotherapy in SUS. Please note that 
the RS state recently approved a State Policy on Integrative and Complementary Practices 
(EPCIP/RS), through Resolution 695/2013 CIB,31 which includes various therapeutic 
activities, including the implementation of herbal and medicinal plants in the SUS. 
 The use of herbal medicines was reported by 13 (14,9%) respondents, averaging 
1,38±0,87 for herbal woman being cited 12 different herbal medicines. The most Ginkgo 
biloba has been used (n=7) (Table 1). 
 
Table 1 - Distribution of herbal remedies cited by women registered in the FHSs according to VII 
and VIII, according to autorreferida and frequency of service indication. Ijuí/RS, 2013-2014. 
Phytotherapic 
Statement reported by the 
interviewee 
Frequency of service N 
(%) 
Ginkgo biloba (ginkgo) 
80mg 
Memory, circulation, regulation 
of Ear pressure 
7 (58,33%) 
Cynara scolymus 
(artichoke) 500mg 
Weight reduction 1 (8,33%)   
Aesculus hippocastanum 
(horse chestnut) 100mg 
Varicose veins 1 (8,33%)   
Borago officinalis 
(gamaline) 900mg 
Breast pain 1 (8,33%)   
Paullinia cupana (guarana) 
500mg 
Refreshing 1 (8,33%)   
Glycine max (isoflavone) 
50mg 
Hot flashes 1 (8,33%)   
Linum usitatissimum 
(Flaxseed) 
Weight reduction 1 (8,33%)   
Compound with 37 herbs* Weight reduction 1 (8,33%)   
Compound “Multimix”* Weight reduction 1 (8,33%)   
Compound with 3 herbs* Weight reduction 1 (8,33%)   
Compund “drought belly”* Weight reduction 1 (8,33%)   
Uncaria tomentosa 
(catclaw acacia) 100mg 
Joint pain 1 (8,33%)   
OBS: All herbal included in this table were used by respondents in the pharmaceutical capsule 
form. * It was not considered for the identification of interactions. 
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 Studies have shown a preference for medicinal plants of the population,19-20 on the 
other hand, herbal that are obtained with exclusive use of vegetable raw materials which 
are safe and effective based on clinical evidence and are characterized by their quality 
constancy,32 They do not have the same credibility as medicinal plants. In this study, we 
found that few women used herbal, probably because they are not considered by them, 
without risk just as medicinal plants, or the high frequency of home cultivation of plants 
for consumption by the interviewees, and present a lower cost compared to herbal. 
In Uberlandia/MG, the use of herbal medicines was reported by 5,5% of 
respondents, and Ginkgo biloba the most widely used herbal medicine,20 similar to this 
study. Ginkgo biloba is among the herbal recognized by the Ministry of Health, is indicated 
for dizziness and tinnitus (tinnitus) resulting from circulatory disorders, peripheral 
circulatory disorders (intermittent claudication) and cerebral vascular insufficiency,30 also 
is used to improve cognitive function in cases of dementia and memory loss17, is in 
conformity with the indications reported by women in the study. It is noteworthy that in 
this study the Ginkgo biloba herbal medicine was the most involved in interactions, 
probably because it was mostly used by women, as has been widely reported by the media 
and the fact that the plant affects various cytochromes P450. Another fact that may 
explain the higher frequency of interactions related to herbal medicine that is related to 
its ancient use and the numerous queries related to this product.  
 In a study conducted in Maracanau/EC, the Family Health Units of users, of which 
85,4% were women with an average age of 36,93±15,9, it was found prevalence of 20,6% 
of herbal medicines in prescriptions, possibly due to the municipality develop Vivas 
Pharmacies program in the public health system,4 which is not the reality of the studied 
FHSs. 
 When women were asked of being informed by the doctor about the use of 
medicinal plants and herbal medicines, the majority (57,32%) said no report, which was 
also observed by Machado et al.20 It should be noted that the prescriber of ignorance level 
on the use increases the risk to the user, especially when with plants and concomitant 
herbal drug self-medication is carried and can have the effect of synergistic effects or 
lack of effect, and those not covered by doctor.33 in relation to situations in which 
concomitant use of the products under study resulting in reduced effect of some drug 
used, as noted in Tables 2 and 3, can induce the physician to prescribe an unnecessary 
drug and further worsen the health condition patients lack the desired effect. On the 
other hand, if the doctor is informed about the use of plants and/or herbal, study Da Rosa 
et al.34 shows a lack of knowledge of these professionals about this therapy, which can 
cause them to disregard the patient's report on the Use of plant and/or herbal medicines.
  
 On the use of drugs, 59 (67,82%) respondents said they use at least one, averaging 
3,37±2,71 per woman, totaling 76 different medications. No statistically significant 
difference was observed (p=0,05) between the number of medicinal plants and the 
number of medications used by women. The most commonly used, according to the ATC,13 
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act on the nervous system (30,6%), which may be related to the fact that this 
classification include analgesics, which are often used by self-medication. In addition, 
this group includes anxiolytics and antidepressants that were also cited by respondents. 
The second highest rate was for medicines for diseases of the cardiovascular system, 
suggesting the presence of hypertensive women, given the high prevalence of the disease 
in the general population. These data are similar to the study of Teutonic/RS, with a 
population with an average age of 44,4±13,9 years, 87,2% women, in which the most 
commonly used medications act on the nervous system (25,7%), followed by acting on the 
cardiovascular system (18,4%).19  
 No respondent reported discontinue use of plant and/or herbal when used 
concurrently to any medicine by the manifestation of side effects, which can be explained 
by lack of knowledge about the risk associated with concomitant use of plants and herbal 
medicines with medications, or assign the adverse effect occurred to the drug, mainly 
because most of the respondents (77,01%) reported that plants and/or concomitant 
herbal medicinal products carry no health risks and the majority reported that they may 
complement the action of the drug. 
 In a study conducted in the north central region of the state of Rio de Janeiro, 
47,5% of respondents reported that medicinal plants are used together with drugs, 
whenever know a plant that may be indicated for the treatment they need.33 In the 
present study, we found higher results in relation to such conduct, increasing the risk of 
interactions, as of 59 women who used drugs, 55 (93,22%) used at least one medicinal 
plant and a drug concomitantly a total of 26 (47,27%) women exposed to interactions 
between plants and medicines, eight (30,77%) are exposed to more than one interaction. 
34 were identified potential interactions, averaging 1,85 interactions per woman. 
 Among the plants used by the interviewees, which may interact with medications 
used for them, it was found that the Camellia sinensis (black/green tea) and Pyros Malus 
(Apple) are not recognized therapeutic use by the Ministry of Health, as are not in national 
relationships published to date.26-27-28-29-30 Please note that most interactions involve 
chronic drug use, which exposes women to interactions for long periods. It is mainly for 
this reason that it is necessary to inform the doctor about the use of medicinal plants and 
which plants used concomitantly with medications because with this information the 
doctor can opt for medicines that do not interact with the plants used or can replace tea 
to avoid interactions with medicines used. 
 As the severity of the interactions has been found in the data bases 11 (32,35%) 
are lower risk, 14 (41,18%) had moderate/significant three (8,82%) larger/serious. It was 
found that for three (8,82%) interactions there is doubt about the result of the 
simultaneous use, one (2,95%) presents significant risk to the patient17 and about two 
(5,88%) interactions were not found to severity18 reports (Table 2). 
 It was observed that the three potential interactions between herbal and major/ 
serious severity of medicines involving Hypercum perforatum (St. John's wort), indicated 
for the treatment of mild to moderate depression, seasonal affective disorders, bad 
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mood, anxiety and insomnia, particularly if associated with menopause17 In addition to 
the plant in nature, are available in the herbal market containing this plant, which could 
be prescribed by doctors with guidelines on the use, and most likely to achieve the correct 
dose, which is not guaranteed with the plant, since the also influenced the method of 
preparation of tea and lack of standardization. Evidence suggests that it exerts a biphasic 
effect on several cytochromes P450, with inhibitions observed in in vitro studies with an 
initial exposure and induction resulting from long-term use. In the case of the interaction 
of Hypericum perforatum with estradiol, prednisone, and carbamazepine, the three 
largest potential/serious interactions observed in this study, there is induction of CYP3A4 
activity, thus reducing the serum levels and effects of said drugs, and the output appears 
vary in accordance with the present hyperforin content in the plant.17 
Table 2 presents the potential interactions between herbal medicines and 
identified in menopausal women enrolled in FHSs VII and VIII. 
 
Table 2 - Potential interactions between herbs and drugs identified in weather women registered 
in the FHSs VII and VIII. Ijuí/RS, 2013-2014. 
Medicinal plant Medication Effect Severity N (%) 
 Ibuprofen 15 
↑ risk for 
bleeding 
Moderate/signi
ficant 
2 (4,17%) 
 Propranolol15 
↑ effect of 
propranolol 
Minor 
 
2 (4,17%) 
Plectranthus 
barbatus (false 
Bilberry) 
Metformin15 
 stimulation of 
insulin 
liberation 
Minor 
 
1 (2,08%) 
 Ketoprofen15 
↑ risk of 
bleeding 
Moderate/signi
ficant 
1 (2,08%) 
  Drospirenone15 
↑ effect of 
drospirenone 
Minor 
 
1 (2,08%) 
 Hydrochlorothiazide15 
↑ effect of 
hydrochlorothia
zide 
Minor 
 
1 (2,08%) 
 
Estradiol14-15-16- 
17-18 
↓ effect of 
estradiol 
Greater/ 
Serious 
1 (2,08%) 
 Clonazepam14 
↓ effect of 
clonazepam 
Moderate/signi
ficant 
1 (2,08%) 
Hypericum 
perforatum (St. 
John's wort) 
Cafein (Neosaldina)17 
↑ metabolismo 
of cafein 
Minor 
 
1 (2,08%) 
 Prednisone15,17 
↓ effect of  
prednisone 
Greater/ 
Serious 
1 (2,08%) 
 
Carbamazepine14-15-16-
17 
↓ effect of 
carbamazepina   
Greater/ 
Serious 
1 (2,08%) 
Alprazolam14-15-16-17 ↓ effect of Moderate/ 1 (2,08%) 
ISSN 2175-5361                                                DOI: 10.9789/2175-5361.2016.v8i2.4328-4346           
Gelatti GT, Oliveira KR, Colet CF.                                           Potential drug interactions … 
 
 
 
J. res.: fundam. care. online 2016. abr./jun. 8(2):4328-4346 4337 
 
alprazolam significant 
 
 Clonazepam15 ↑ sedation Minor 1 (2,08%) 
Eucalyptus 
globulus 
(eucaliptus) 
Estradiol15 
↓ effect of 
estradiol 
Moderate/ 
significant 
1 (2,08%) 
Alprazolam15 
↑ sedation, 
↓ effect of 
alprazolam 
Moderate/ 
significant 
1 (2,08%) 
 
Salvia 
officinalis 
(sage) 
Codein15 ↑ sedation Minor 1 (2,08%) 
 Metphormine15 
↑ effect of 
metphormine 
Minor 1 (2,08%) 
 
Acetylsalicylic acid 
(AAS)15,18 
↓ effect of 
chamomile, 
↑ risk of 
bleeding 
Moderate/ 
significant 
4 (8,32%) 
 Prednisone15 
↓ effect of 
chamomile 
Minor 
 
2 (4,17%) 
Matricaria 
recutita 
(chamomile) 
Ketoprofen15 
↓ effect of 
chamomile, 
↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
 Clopidogrel18 
↑ risk of 
bleeding 
Not found 1 (2,08%) 
 Clonazepam18 ↑ sedation Not found 1 (2,08%) 
 Ibuprofen15 
↓ effect of 
chamomile, 
 ↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
 Diclofenaco15 
↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
 Enalapril17 
↑ moderate in 
blood pressure 
There is doubt 
about the use 
of 
simultaneous 
use 
3 (6,25%) 
 
 
Camellia 
sinensis (black 
tea/green) 
Hidroclorotiazida17 
↑ moderate in 
blood pressure 
There is doubt 
about the use 
of 
simultaneous 
use 
2 (4,17%) 
 Fluoxetina15 
↑ risk of 
bleeding 
Moderate/ 
significant 
2 (4,17%) 
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 Ibuprofen15 
↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
 Litium15,18 
↑ levels of 
litium 
Minor 1 (2,08%) 
Cinnamomum 
verum 
(cinnamon) 
Ibuprofeno15 
↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
Pyrus malus 
(apple) 
Hydrochlorothiazide15 hypokalemia Minor 1 (2,08%) 
 
 
Pimpinela 
anisum (fennel) 
Estradiol17 
active 
constituents of 
fennel seem 
shows 
estrogenic 
activity 
There is doubt 
about the 
result of the 
simultaneous 
use 
3 (6,25%) 
 Diclofenaco15 
↑ risk of 
bleeding 
Moderate/ 
significant 
1 (2,08%) 
Mentha x 
piperita (mint) 
Omeprazol17 
↓ effect of 
omeprazol 
Significant risk 
to the patient 
3 (6,25%) 
Total 34 - - 48 (100%) 
  
 
The most frequent interaction was observed Matricaria recutita (chamomile) with 
AAS, as four women are exposed. These may incur to reduce the effects of Matricaria 
recutita,15 and it can increase the risk of bleeding because the cumarin present in the 
plant exert discreet anticoagulant effect. It is noteworthy also that the improper storage 
(exposure to moisture) causes the production of dicumarol.18 
 Three other potential interactions were common: Camellia sinensis (black tea/ 
green) with enalapril, Pimpernel anisum (anise) with estradiol and Mentha x piperita 
(mint) with omeprazole. 
 The excessive intake of Camellia sinensis (tea black/green) can be an increase in 
blood pressure, but this increase seems to be small and not necessarily maintained during 
long-term use. The presence of caffeine between the components of the black/ green 
tea, which is an antagonist of endogenous adenosine is responsible for vasoconstriction 
increases blood pressure.17 Hypertensive crisis may occur in these three women exposed 
to above interaction (Table 2), but as they reported that they never stopped using plants 
due to expression of any side effects, possibly, if there was an increase in blood pressure, 
was probably attributed to the drug in use, which was not being effective, or, if not often 
monitored the pressure, the interaction may have gone unnoticed. In this case, the 
doctor's ignorance about the interaction could induce him to increase the dosage of 
antihypertensive used, or add another medicine to treat user, making the most complex 
treatment and can cause adhesion problems, besides representing higher economic 
impact to the system. 
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 The active constituents of Pimpinella anisum (anise) seem shows estrogenic 
activity and can compete for the same estrogen receptor those hormonal drugs, and there 
may be synergism or antagonism, but the clinical relevance of this data is not fully 
elucidated, since this interaction is based only experimental evidence.17 
 Sharp increase in gastric pH caused by antacids may result in premature dissolution 
of the enteric coating and release of the oil of Mentha x piperita (peppermint) in the 
stomach, which increases the risk of heartburn with this formulation.17 However, this 
women study used the tea plant, in this case, the small percentage or absence of oil after 
preparation is not enough to cause an interaction. 
In addition, of the 59 women who use drugs, nine (15,25%) used at least one herbal 
medicine and concurrently, totaling six (66,7%) women exposed to interactions between 
herbal medicines and medicines with more than five (55,5%) are exposed to more than 
one interaction. 16 potential interactions averaging 3,17 interactions per woman were 
identified. For severity, it was found that one (6,25%) interaction has doubt about the 
result of the simultaneous, 17 13 (81,25%) were moderate/significant risk and two (12,5%) 
interactions not severity.18 Reports were found of the nine herbal analyzed, two had 
potential interactions with medications (Table 3). 
 
Table 3 - Potential interactions between herbal medicines and identified in menopausal women 
registered in FHSs VII and VIII. Ijuí/RS, 2013-2014. 
Phytotherapic Medication Effect Severity N (%) 
 Omeprazol14,17 
↓ effect of 
omeprazol 
Moderate/ 
significant 
3 (15,9%) 
 Enalapril18 
aggravated 
bradycardia and 
hypotension 
Not found 2 (10,4%) 
 Fluoxetin14,16,18 
↑ serotonin 
syndrome risk 
(hypertension, 
hyperthermia, 
myoclonus, 
mental status 
changes), 
↑ risk of 
convultions 
Moderate/ 
significant 
1 (5,26%) 
Ginkgo biloba 
(ginkgo) 
Duloxetin16 
↑ risk of 
convultions 
Moderate/ 
significant 
1 (5,26%) 
 Paroxetina14,16,18 
↑ risk of serotonin 
syndrome, 
↑ risk of 
convultions 
Moderate/ 
significant 
 
1 (5,26%) 
 Nortriptilina16,18 
↑ risk of 
convultions, 
Moderate/ 
significant 
1 (5,26%) 
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cardiac 
arrhythmias and 
side effects (dry 
mouth, 
tachycardia, 
urine retention, 
sedation) 
 
 Amitriptilina16,18 
↑ risk of 
convulsions, 
cardiac 
arrhythmias and 
side effects (dry 
mouth, 
tachycardia, 
urine retention, 
sedation) 
Moderate/ 
significant 
 
1 (5,26%) 
 Cytalopram14,16 
↑ risk of 
serotonina 
syndrome, 
↑ risk of 
convultions 
Moderate/ 
significant 
 
1 (5,26%) 
 
Ácido acetilsalicílico 
(AAS)14-15-16-17-18 
↑ risk of bleeding 
Moderate/ 
significant 
 
1 (5,26%) 
Ginkgo biloba 
(ginkgo) 
Pregabalina16 
↑ risk of 
convultions 
Moderate/ 
significant 
 
1 (5,26%) 
 Clortalidona16 ↑ blood pressure 
Moderate/ 
significant 
 
1 (5,26%) 
 Ciclobenzaprina16 
↑ risk of 
convultions 
Moderate/ 
significant 
1 (5,26%) 
 Diazepam14,16 
↑ risk of 
convultions 
↓ efficacy of 
diazepam 
Moderate/ 
significant 
 
1 (5,26%) 
 Atenolol18 
aggravated 
bradycardia and 
hypotension 
Not found 1 (5,26%) 
 
Hydrochlorothiazide 
14,16 
↑ blood pressure 
Moderate/ 
significant 
1 (5,26%) 
Uncaria 
tomentosa 
(catclaw 
acacia) 
Atenolol + 
chlorthalidone17 
the additive 
effect ↓ of blood 
pressure 
There is 
doubt about 
the 
symultaneous 
1 (5,26%) 
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use  
Total 16 - - 19 (100%) 
 
  
In a study conducted in Belo Horizonte/MG,35 45% of herbal users elderly were 
exposed to at least one drug interaction between herbal medicines and traditional 
medicines. In the present study was found an increased number of interactions exposure, 
most of which involved Ginkgo biloba and steady medication such as antidepressants and 
antihypertensive drugs, probably because these drugs were the most used after 
analgesics, women this study. 
 It was observed potential interaction between aspirin and Ginkgo biloba, since 
both interfere with blood clotting, therefore, when used concomitantly can cause 
synergism, increasing the platelet aggregation inhibition, and there is risk of bleeding. 
This is because the ginkgo extract contains ginkgolideum B, which is a potent inhibitor of 
platelet activating factor.14-15-16-17-18 
 Concomitant use of Ginkgo biloba and omeprazole may result in reduced efficacy 
of omeprazole, it may occur increased metabolism (hydroxylation) of omeprazole by 
inducing isoenzymes CYP2C 19 cytochrome P450.17 The three women exposed to this 
interaction may have increased production of stomach acid and may have gastritis, reflux, 
among other symptoms. 
 When Ginkgo biloba is used with selective serotonin reuptake (fluoxetine, 
paroxetine, and citalopram) may increase the risk of serotonin syndrome (hypertension, 
hyperthermia, myoclonus, altered mental status),14 as well as seizures.16 Symptoms 
usually occur within the first six hours after administration of the drugs, and the initial 
symptoms are tremor, akathisia and diarrhea.18 These interactions, despite having 
moderate/significant severity, reinforce the importance of informing the doctor about 
the herbal drug administered concomitantly, since the serotonin syndrome can be fatal. 
 Some preparations of Ginkgo biloba can cause seizures, and use it with duloxetine, 
pregabalin, cyclobenzaprine, diazepam, amitriptyline and nortriptyline can increase this 
risk. Among the constituents of Ginkgo, there are varying amounts of 4-O-methyl 
pyridoxine (ginkgotoxin), a neurotoxin mainly found in the seeds and in minor amounts in 
the leaves. In vivo, 4-O-methyl pyridoxine competes with vitamin B6, which causes 
indirect inhibition of glutamate decarboxylase, which in turn results in the induction of 
seizures by decreasing levels of gamma-aminobutyric acid (GABA) in the brain. The 
interaction may be more likely in the elderly, individuals with a history of seizures, or 
disease that affects the central nervous system, such as a brain tumor or cranial trauma.16 
In addition, concomitant use with amitriptyline and nortriptyline can trigger cardiac 
arrhythmias and side effects with xerostomia, tachycardia, sedation and retention of 
urine and 18 when used concurrently with diazepam may occur decreased effect of this 
drug.14 
 On the interactions of Ginkgo biloba with antihypertensive drugs, it was found that 
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when administered concomitantly chlorthalidone or hydrochlorothiazide may occur 
change in the effects of these drugs, which may cause increased blood pressure.14,16 With 
atenolol and enalapril may experience worsening of bradycardia and hypotension, but the 
mechanism of these three interactions is unknown.18 
 As the herbal Uncaria tomentosa (cat's claw), it was found that can interact with 
chlorthalidone, since it has hypotensive effect, which occurs due to the vasodilation 
effect and the momentary reduction in the frequency and force of cardiac contraction. 
Therefore, there may be additive effects in lowering blood pressure with concomitant 
use of these two substances.17 The occurrence of this interaction is characterized by 
hypotension, weakness, dizziness, and other symptoms, which may be related by the user 
or the healthcare team with excess drug effect in use. 
 In this study the interactions were identified in which women studied are exposed; 
it is difficult to detect the actual occurrence of an interaction, especially for biological 
variation observed among patients. Moreover, it is expensive and requires complex and 
specific analytical methods for estimating which the active principles present in plants 
and the concentration of each when used as teas, because the method of extraction 
affects the composition and therefore its potential interaction. Still, the plant extracts 
differ from drugs, because they are complex mixtures of various bioactive compounds, 
making it difficult to evaluate the contribution of each constituent in the overall 
activity.17 
 In this context, the indiscriminate use of plant and/or herbal medicines to treat 
diseases should be viewed more closely by the population, but apparently harmless 
plants, and used as a medicament may be demonstrably hazardous, depending on the way 
they are administered, and this risk is more present when the user combines use with 
drug .2 In this study, few women used herbal medicines, but a high percentage used 
plants, averaging four/person and about 70% of women used drugs, averaging three/ 
person, exposing the interactions with different degrees of severity. It is noteworthy that 
identified in interviewees' reports which, according to them, the use of plants and/ or 
herbal concomitant drug does not imply risks to health and the plant complements or 
enhances the action of the drug. The results of the interactions which women are 
exposed, shown in Tables 2 and 3 indicate the need for interventions related to 
pharmacotherapy, in order to avoid possible damage to health and optimize the effect of 
both the drug as plant and/or herbal. For such action is necessary to science both to 
prescribers about the products in use, for the women who practice self-medication with 
herbal plants and seeking rationalization of therapy. 
 Undeniably, medicinal plants and herbal medicines play an important role in 
therapy, however, the belief "that is natural does not hurt" causes the majority of the 
population does not relate to the possibility of adverse events and this may be one of the 
reasons to consider irrelevant communicate the doctor on the concomitant use of 
medicinal products, as observed in this study. Still, free access to the plants, such as in 
supermarkets, fairs, cultivation in their own homes, makes the population believe that 
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guidance on the use are unnecessary. 
 In addition, the population in some cases, do not have knowledge of the species 
and quality of the plants you are using, which could be achieved with the adoption of 
Living Pharmacies, because through them, medicinal plant gardens could be installed next 
to health units and community centers providing medicinal plants for free to the 
population, which could make your home pharmacy with plants certified by botanists and 
even women could be educated on best practices of use, with the design and proper 
dosage, guided by a responsible pharmacist.24 
 From the results obtained and considering that this study was conducted in FHSs, 
it is necessary to propose intervention strategies to avoid possible drug interactions and 
self-medication with medicinal plants and herbal medicines. In this sense, it is suggested 
actions aimed at raising awareness and training of physicians regarding the safe use of 
medicinal plants and herbal associated or not the drugs, which could be launched from 
the herbal medicines listed in RENAME. It would also be important to train community 
health workers using as a working tool the materials of the Ministry of Health, as PNPIC 
and official lists of medicinal plants, in order to subsidize them to guide and answer 
questions from users about it, and to identify user demands and present them to health 
teams. Other important aspects include discussing the possibility and interest in 
implementing a Living Pharmacy in the city, alert users to inform the doctor about the 
concomitant use of medicinal plants, herbal and medicine, exercise caution with elderly 
patients and polymedicated and even inform the population about risks related to the use 
of "natural products". 
 The limitations of the study, it is emphasized that the sample was small, was not 
analyzed the dosage of herbal medicines and drugs, or the method of preparation of tea, 
or the time of use thereof by the interviewees, which are factors that do not directly 
influence identification of potential interactions, but in consideration thereof, which can 
be performed in future studies. 
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The popularity of using "natural products" is important to the understanding of the 
potential interactions between herbal medicines, herbal medicines and medicines, as 
well as monitoring the concurrent use by health professionals, to identify the occurrence 
of interactions that can compromise the user's health. 
 This research revealed that women studied are exposed to interactions resulting 
from the use of medicinal plants and herbal concomitant drug, indicating high frequency 
of this adverse event. Most of the identified interactions are moderate/significant risk, 
which can cause damage to the user, followed by the lower risk of interactions, which 
should also be analyzed with caution, since in many cases may imply additional 
treatment, ie when reduction occurs the effect of some of the medications used the trend 
is that another drug is added to the treatment or the drug may have questioned its effect 
may be replaced. 
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